Soft Tissue Infections

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Barrier Breach: Soft tissue infections (SSTIs) initiate via a disruption in the skin's mechanical barrier (due to trauma, inflammation, or existing lesions), allowing for the invasion of local flora, most commonly Staphylococcus aureus (including MRSA) and Group A Streptococcus.
• Abscess Formation: The process begins as a localized superficial cellulitis. The invading organisms trigger necrosis and liquefaction of tissue, leading to an accumulation of leukocytes and cellular debris. The body subsequently loculates and walls off these infectious byproducts, creating a distinct, pressurized cavity (the abscess) within the dermis and subcutaneous fat.
• Necrotizing Acute Soft Tissue Infection (NASTI): This is a fulminant, life-threatening progression characterized by the rapid destruction of the muscle fascia and overlying subcutaneous fat. Driven by either monomicrobial (Group A Strep) or polymicrobial/anaerobic invasion, the infection spreads violently along fascial planes due to poor blood supply in these tissues, leading to systemic toxicity, shock, and rapid tissue death.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Immediate Stabilization: Assess ABCs, especially if the patient appears toxic, as severe SSTIs can rapidly progress to septic shock. Mark the leading edges of any cellulitis or erythema with an indelible marker to objectively monitor progression. Elevate the affected extremity to facilitate edema drainage.
• Outpatient/Uncomplicated Management:
• Nonpurulent Cellulitis: Cephalexin 500 mg PO QID for 5–10 days (use Clindamycin 450 mg PO TID if severe penicillin allergy exists).
• Purulent Cellulitis/Abscess: Incision and drainage (I&D) is the definitive treatment. For adjunctive oral coverage (if >5cm, multiple lesions, or comorbidities exist), use Trimethoprim-Sulfamethoxazole (TMP-SMX) 1-2 DS tabs PO BID or Doxycycline 100 mg PO BID.
• Inpatient/Severe Management (Sepsis/NASTI):
• Initiate aggressive critical care fluid resuscitation.
• Administer broad-spectrum empiric antibiotics: Vancomycin (15–20 mg/kg IV) plus Piperacillin/Tazobactam (Zosyn) or a Carbapenem (e.g., Meropenem).
• Critical Titration: In any suspected necrotizing infection, you must add Clindamycin (600-900 mg IV) specifically for its mechanism of inhibiting bacterial toxin production.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• Critical "Can't-Miss" Mimics:
• Deep Vein Thrombosis (DVT) or Superficial Thrombophlebitis.
• Compartment Syndrome.
• Toxic Shock Syndrome (TSS).
• Staphylococcal Scalded Skin Syndrome (SSSS).
• Prioritized Diagnostic Workup:
• Routine Labs/Cultures: Do not routinely obtain superficial wound swabs in the ED, as they are highly prone to contamination with skin flora. Routine blood work is generally unnecessary for healthy patients with simple, localized abscesses.
• The Systemic/Toxic Workup: If the patient is febrile, tachycardic, immunocompromised, or NASTI is suspected, immediately order a CBC, Comprehensive Metabolic Panel, C-reactive protein (CRP) or procalcitonin, and obtain blood cultures from all lumens prior to antibiotic administration.
• Gold-Standard Imaging: Point-of-Care Ultrasound (POCUS) is the initial modality of choice to differentiate simple cellulitis from an occult abscess. CT or MRI is indicated to assess for deep-space infections or necrotizing fasciitis.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The POCUS View: Utilize a high-frequency linear probe. An abscess will visually present as an anechoic or hypoechoic fluid collection. Compress the area with the probe; the visualization of moving purulent debris inside the cavity is known as the classic "squish sign" or "swirl sign," which confirms a drainable abscess.
• The CT Scan (NASTI): Look for asymmetric fascial thickening, deep focal fluid collections, and the hallmark, definitive finding of gas tracking along fascial planes (subcutaneous air).
• The Clinical Visual:
• Erysipelas: A bright red, raised, and sharply demarcated border separating infected from normal skin.
• Necrotizing Fasciitis: Look for dark, hemorrhagic, or bluish bullae, patchy skin necrosis, extensive ecchymosis, and palpable soft tissue crepitus.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The LRINEC Score: The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score is a validated clinical decision tool used to risk-stratify patients presenting with severe SSTIs to determine the likelihood of a necrotizing infection.
• Disposition Criteria:
• Safe for Discharge: Patients with small (<2 cm surrounding erythema), uncomplicated infections who are afebrile, hemodynamically stable, immunocompetent, and capable of performing home wound care.
• Mandatory Admission: Patients demonstrating signs of systemic toxicity (fever, altered mental status, poor perfusion), rapidly spreading erythema, failed outpatient therapy, diabetic foot infections involving deep structures, or any suspicion of necrotizing fasciitis.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• The "Pain Out of Proportion" Trap: Pitfall: Assuming extreme pain in an area of mild cellulitis is just poor pain tolerance. Critical Action: Pain out of proportion to physical exam findings is the earliest and most lethal hallmark of a necrotizing infection; it mandates immediate surgical consultation.
• The Imaging Delay: Pitfall: Delaying surgical debridement of a suspected necrotizing fasciitis while waiting for an MRI or CT scan. Critical Action: The mortality for NASTI approaches 100% without surgery; prompt surgical exploration and aggressive debridement is the definitive diagnostic and therapeutic maneuver.
• The Dual-Antibiotic Fallacy: Pitfall: Routinely prescribing dual antibiotic therapy (e.g., Cephalexin + TMP-SMX) for uncomplicated, nonpurulent cellulitis. Critical Action: Multiple trials show no benefit to adding MRSA coverage for simple nonpurulent cellulitis; use targeted monotherapy.
• The Deep-Space Blindspot: Pitfall: Missing a deep-space infection from a palmar or plantar puncture wound. Critical Action: Always examine the dorsum of the hand or foot; redness tracking on the dorsal aspect suggests a dangerous deep-space infection requiring surgical washout.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzwords:
• "Pain out of proportion to exam," "crepitus," or "hemorrhagic bullae" = Necrotizing Fasciitis.
• "Sharply demarcated, raised, bright red border" on the face or lower extremity = Erysipelas (caused by Group A Strep).
• "Honey-colored crust" = Impetigo (treat with topical mupirocin).
• "Squish sign" or "swirl sign" on ultrasound = Abscess.
• Distractor Differentiation: An exam question will often offer "Obtain a superficial wound culture in the ED" for a patient with an uncomplicated abscess. Differentiate: This is an incorrect distractor. Routine ED wound cultures are highly prone to skin flora contamination and do not alter immediate management; rely on empiric I&D. Another classic trick is offering "Administer IV Vancomycin and Piperacillin-Tazobactam" for a patient with necrotizing fasciitis, omitting Clindamycin. Differentiate: The correct answer will always include Clindamycin for its specific toxin-inhibiting properties.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• Gathering the Baseline: "I am immediately assessing the patient's ABCs and vital signs to rule out septic shock. I will completely expose the affected area, mark the leading edges of the erythema with a surgical marker, and record the time to monitor progression."
• Executing the Physical Exam & Imaging: "I am specifically palpating the tissue for crepitus, looking for hemorrhagic bullae, and assessing if the patient's pain is out of proportion to my exam to rule out a necrotizing infection. I will perform a bedside point-of-care ultrasound using a high-frequency linear probe to evaluate the soft tissue for anechoic fluid collections or a swirl sign indicating an occult abscess."
• Articulating the Management & Disposition: "Because this patient exhibits signs of systemic toxicity and pain out of proportion, I am highly concerned for a necrotizing acute soft tissue infection. I am initiating aggressive IV fluid resuscitation and ordering a STAT lactate, CBC, and blood cultures. I am immediately starting broad-spectrum antibiotics including Vancomycin, Piperacillin-Tazobactam, and Clindamycin to inhibit toxin production. My critical action is to obtain an emergent general surgery consultation for operative exploration and debridement."